2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Stomach Neoplasms
57
Carcinoma, Hepatocellular
45
Carcinoma, Non-Small-Cell Lung
23
Small Cell Lung Carcinoma
19
Ovarian Neoplasms
18
Colorectal Neoplasms
18
Breast Neoplasms
17
Sarcoma
14
Neoplasms
14
Triple Negative Breast Neoplasms
13
Nasopharyngeal Carcinoma
11
Lung Neoplasms
10
Esophageal Squamous Cell Carcinoma
10
Cholangiocarcinoma
10
Osteosarcoma
9
Esophageal Neoplasms
9
Advanced Gastric Cancer
9
Neoplasm Metastasis
8
Biliary Tract Neoplasms
8
Uterine Cervical Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
6
Recurrence
6
Pancreatic Neoplasms
6
Head and Neck Neoplasms
6
Liver Neoplasms
5
Glioma
5
Thyroid Neoplasms
4
Solid Tumor
4
Melanoma
4
Drug-Related Side Effects and Adverse Reactions
4
Interventions
endostar protein
1
coenzyme Q10
1
apatinib
1
Yoga
1
Ubiquinone
1
Tamoxifen
1
Surveys and Questionnaires
1
Referral and Consultation
1
Quality of Life
1
Palliative Care
1
Oxaliplatin
1
Melatonin
1
Gardening
1
Fentanyl
1
Exercise
1
Educational Status
1
Diet Therapy
1
Chemoradiotherapy
1
Capecitabine
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Quality of Life
×
apatinib
×
Clear all
NCT02998242
2019-05-21
ARCAP
Sichuan Provincial People's Hospital
Phase NA
Completed
40 enrolled